{"id":"NCT00396565","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia","officialTitle":"A Placebo-Controlled Double Blind Comparative Study of JNS007ER in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-11-07","resultsPosted":"2012-07-03","lastUpdate":"2014-04-29"},"enrollment":394,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"ER OROS paliperidone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Olanzapine","otherNames":[]}],"arms":[{"label":"ER OROS paliperidone","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Olanzapine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the effectiveness and safety of Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) Paliperidone compared to placebo in patients with Schizophrenia. Olanzapine will be used as a reference drug in the study.","primaryOutcome":{"measure":"Change From Baseline in the Total Positive and Negative Syndrome Scale (PANSS).","timeFrame":"Baseline and 6 weeks","effectByArm":[{"arm":"Paliperidone Extended Release (ER) (JNS007ER)","deltaMin":-9.1,"sd":18.39},{"arm":"Placebo","deltaMin":3.8,"sd":18.88},{"arm":"Olanzapine","deltaMin":-9.9,"sd":16.83}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":56,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=412&filename=CR012625_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":134},"commonTop":["schizophrenia","Insomnia","Nasopharyngitis","Blood creatine phosphokinase increased","Constipation"]}}